We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




A Bioengineered Tooth Erupts Into Being

By LabMedica International staff writers
Posted on 20 Aug 2009
A new study describes the transplantation of a bioengineered tooth germ into alveolar bone of a mouse and its development into a fully functioning tooth, and proposes this as a model for future organ replacement therapy.

Researchers at Tokyo University of Science (Chiba, Japan), Organ Technologies (Tokyo, Japan), Tohoku University (Miyagi, Japan) and Tokyo Medical and Dental University (Japan) reconstituted a bioengineered molar tooth germ--that had developed at the early bell stage of a natural tooth germ--which was then transplanted with the correct orientation into an alveolar bone extraction site in the upper first molar region of an 8-week-old adult mouse. More...
The cusp tip of the bioengineered tooth was then exposed into the oral cavity, and the vertical dimension of the tooth crown continually increased until the bioengineered tooth finally reached the plane of occlusion with the opposing lower first molar, 49 days after transplantation. During the course of eruption and occlusion, the alveolar bone gradually healed in the areas around the bioengineered tooth and the regenerated tooth had sufficient periodontal space between itself and the alveolar bone. The bioengineered tooth also formed a correct structure comprising enamel, ameloblast, dentin, odontoblast, dental pulp, alveolar bone, and blood vessels.

The researchers also evaluated the perceptive potential of the neurons that developed in the bioengineered tooth against noxious stimulations such as orthodontic treatment and pulp stimulation. The expression of galanin (a neuropeptide involved in pain transmission) increased in response to persistent painful stimulation of the nerve terminals within the periodontal ligament (PDL) of the bioengineered tooth to the same extent as in a normal tooth. The PDL nerve fibers in the bioengineered tooth appeared to respond to nociceptive stimulation caused by experimental tooth movements. Using sophisticated techniques for tracking genes with a fluorescent protein, the researchers also showed that genes that are normally active in tooth development were active during the bioengineered replacement tooth's growth. The study was published in the August 3, 2009, edition of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS)

"This study provides evidence of a successful replacement of an entire and fully functioning organ in an adult body through the transplantation of bioengineered organ germ, reconstituted by single cell manipulation in vitro,” concluded lead author Etsuko Ikeda, D.D.S., of Tokyo University of Science, and colleagues. "Further studies on the identification of available adult tissue stem cells for the reconstitution of a bioengineered tooth germ and the regulation of stem cell differentiation into odontogenic cell lineage will help to achieve the realization of tooth regenerative therapy for missing teeth.”

Related Links:
Tokyo University of Science
Organ Technologies
Tohoku University
Tokyo Medical and Dental University


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.